Editor in Chief Dr KK Aggarwal, Padma Shri Awardee                                                                               Dated:29 July,2020

No hosp screening for asymptomatic +ve patients now

Nagpur: With city and district administrations implementing the policy of home isolation for asymptomatic positive patients, entire focus was shifted to taking care of symptomatic and severe patients on Tuesday. It had been decided to screen all positive patients at government hospitals, and discharge those clinically assigned as asymptomatic for 17 days of home isolation.
By evening, the Covid Care Centres (CCCs) were asked not to refer any ‘asymptomatic’ positive patients for screening to government hospitals, and instead discharge them based on examination of in-house medical staff. However, doctors said none of the CCCs have a physician, X-ray and ECG machines, and lab for analysing a patient as asymptomatic. The staff includes mostly BAMS doctors and paramedics. ....read more


CMAAO Coronavirus Facts and Myth Buster: COVID Illness in Bangladesh

With inputs from Dr Monica Vasudev
1018: Minutes of Virtual Meeting of CMAAO NMAs on “CMAAO view on COVID-19 in Bangladesh”25th July, 2020, Saturday; 9.30 am-10.30 am, Participants ,Member NMAs: Dr KK Aggarwal, President CMAAO; Dr Yeh Woei Chong, Singapore Chair CMAAO; Dr Marie Uzawa Urabe, Japan; Dr Ashraf Nizami, Pakistan; Dr Sajjad Qaisar, Pakistan; ,Dr Md Jamaluddin Chowdhury, Bangladesh,Invitees: Dr Russell D’Souza, UNESCO Chair in Bioethics, Australia; Dr S Sharma, Editor IJCP Group ,Dr Md Jamaluddin Chowdhury from the Bangladesh Medical Association presented data on the situation of COVID-19 in Bangladesh. This was followed by a discussion among the participating NMAs on COVID-19 status in Bangladesh. ....read more


World Covid Meter 28th July India Number 3, 213 Countries

Cases: 1M April 2, 2M April 15, 3M April 27, 4M May 8, 5M May 20, 6M May 30, 7M June 7, 8M June 15, 9M June 22, 10M June 29th, 11M July 4, 12M July 8, 13M July 13, 14M July 17, 15M July 23, 16M July 25 ,Ground Zero: Wuhan - in live animal market or cafeteria for animal pathogens: 10th January; Total cases are based on RT PCR, 67% sensitivity ,Coronavirus Cases: 16,642,264,Deaths: 656,488,Recovered: 10,231,567,ACTIVE CASES 5,754,209,Currently Infected Patients 5,687,636 (99%) in Mild Condition ....read more


Significance of Lighting a Lamp in Any Worship

Deepajyothi parabrahma
Deepa Jyotir Janaardanah
Deepo harati paapaani
Sandhyaa deepa namostute
“I prostrate to the dawn/dusk lamp, whose light is the Knowledge Principle (the Supreme Lord), which removes the darkness of ignorance and by which all can be achieved in life.” ....read more


Video of The day

Preventing transmission of COVID 19


Medbytes

       


Healthcare News Monitor
Trump’s orders on drug pricing have pharma industry tuned in for details
Businessline

Is this a pre-poll rhetoric or Covid-driven concern? ,US President Donald Trump’s meeting with representatives of Big Pharma, scheduled for Tuesday, will be watched closely by drug makers around the world including India. ,The cost of delivering healthcare has always played a critical role in US elections and large drugmakers have often borne the brunt of the Presidential campaign rhetoric. This time may be no different, say industry watchers, adding, however, that Covid-19 could have changed things — the rising US toll from the novel coronavirus has hammered home the message of affordable and accessible healthcare. ,The US President’s meeting with drug company heads comes after he signed four executive orders on drug pricing late last week. The aim was to get less expensive drugs for Americans by pricing them along the lines of that paid in other countries.

Express pharma

Most of the large Indian pharma companies have faced some serious issues with USFDA inspection recently. Indian pharma companies are supplying to US market from the late 90s and early 2000s. However, a series of objectionable USFDA inspection outcome is quite a recent phenomenon for about the last five to seven years. A logical question arises that what has fundamentally changed that suddenly Indian companies are facing serious issues with USFDA inspection.
An analysis of the past outcome of USFDA inspections until about 2013-14, shows most of the inspections of Indian pharma companies were classified as either no action initiated (NAI) or voluntary action initiated (VAI). NAI is when at the conclusion of the inspection, no 483 is issued whereas in VAI 483s are issued but USFDA considers that the deficiencies can be mitigated by the firm voluntarily and no adversary official action is required. Today, Indian pharma companies supply about 40 per cent by volume finished dosage pharma products of the US market. So, from the perspective of public safety, regulators in the US are giving much importance to overseas manufacturers like in India. The yardstick and regulatory requirements have also changed dramatically. Most of the Indian companies have failed to improve procedures and processes as the FDA increased the scrutiny.

'Tough few months ahead': Experts on India's coronavirus crisis
aljazeera

New Delhi, India - A sharp increase in India's coronavirus cases in recent weeks has raised concerns over the state of its healthcare infrastructure as well as fears of an extended crisis. ,Nearly 48,000 new reported cases on Tuesday brought India's tally close to 1.5 million, making it the world's third-most affected country behind only the United States and Brazil. The South Asian nation has reported 33,425 deaths so far. ,Three states - Delhi, Maharashtra and Tamil Nadu - account for more than half the cases, with the Indian capital having more than 130,000 cases, well ahead of the other two worst-hit cities - Mumbai and Chennai. ,Last week, a study conducted by the National Centre for Disease Control and released by the federal health ministry found that approximately 23 percent of Delhi's population of 20 million have had the novel coronavirus.

Financial Express

‘Uttar Pradesh joins eSanjeevaniOPD’s five figure club!’ The Ministry of Health made this announcement on its official twitter account. It also said that the state reached the tally of over 10,500 tele consultations on Monday due to the consecutive participation of over 1000 patients in the last two days.In the data released by the Ministry of Health, the state of Uttar Pradesh has completed over 10000 teleconsultations under the eSanjeevaniOPD initiative. With a lot of hospitals turning into dedicated Covid-19 hospitals and the dread of infection keeping patients away from the hospitals, patients are increasingly using the video teleconsultation facility being provided under the scheme to consult with doctors. With over 1000 patients using the platform in the last two days from the state, Uttar Pradesh came in the club of states which have registered more than 10000 teleconsultations of patients with the doctors.